SPC462
Cipaglúkósídasi alfa
Status:
UmsóknApplication date:
27.3.2024Application published:
15.4.2024
Max expiry date:
23.3.2038Medicine name:
PombilitiMedicine for children:
No
Timeline
Today
27.3.2024Application
15.4.2024Publication
23.3.2038Expires
Marketing license
IS authorization number:
EU/1/22/1714Date:
21.4.2023
Foreign authorization number:
EU/1/22/1714Date:
20.3.2023
Owner
Name:
Amicus Therapeutics, Inc.Address:
3675 Market Street, Philadelphia, PA 19104 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3201320